Obstructive sleep apnea and type 2 diabetes: Is there a link?

Frontiers in Neurology

Volumn AUG, Issue , 2012, Pages

  Pamidi, Sushmita ^a   Tasali, Esra ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiovascular; CPAP; Diabetes; Glucose; Insulin; Sleep apnea

Indexed keywords

EID: 84865849948     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00126     Document Type: Article

References (109)

1. American Diabetes Association (ADA). (2010). Standards of medical care in diabetes-2010. Diabetes Care 33(Suppl. 1), S11-S61.
2. Aronsohn, R. S., Whitmore, H., Van Cauter, E., and Tasali, E. (2010). Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am. J. Respir. Crit. Care Med. 181, 507-513.
3. Babu, A. R., Herdegen, J., Fogelfeld, L., Shott, S., and Mazzone, T. (2005). Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med. 165, 447-452.
4. Barcelo, A., Barbe, F., De La Pena, M., Martinez, P., Soriano, J. B., Pierola, J., and Agusti, A. G. (2008). Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 63, 946-950.
5. Bergman, R. N. (2005). Minimal model: perspective from 2005. Horm. Res. 64(Suppl. 3), 8-15.
6. Botros, N., Concato, J., Mohsenin, V., Selim, B., Doctor, K., and Yaggi, H. K. (2009). Obstructive sleep apnea as a risk factor for type 2 diabetes. Am. J. Med. 122, 1122-1127.
7. Brooks, B., Cistulli, P. A., Borkman, M., Ross, G., McGhee, S., Grunstein, R. R., Sullivan, C. E., and Yue, D. K. (1994). Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J. Clin. Endocrinol. Metab. 79, 1681-1685.
8. Carneiro, G., Togeiro, S. M., Ribeiro-Filho, F. F., Truksinas, E., Ribeiro, A. B., Zanella, M. T., and Tufik, S. (2009). Continuous positive airway pressure therapy improves hypoad-iponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab. Syndr. Relat. Disord. 7, 537-542.
9. Celen, Y. T., Hedner, J., Carlson, J., and Peker, Y. (2010). Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J. Clin. Sleep Med. 6, 244-250.
10. Center for Disease Control (CDC). (2011). National Diabetes Fact Sheet, 2011. Atlanta: Department of Health and Human Services,Center for Disease Control and Prevention.
11. Comondore, V. R., Cheema, R., Fox, J., Butt, A., John Mancini, G. B., Fleetham, J. A., Ryan, C. F., Chan, S., and Ayas, N. T. (2009). The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 187, 17-22.
12. Cooper, B. G., White, J. E. S., Ashworth, L. A., Alberti, K. G. M. M., and Gibson, G. J. (1995). Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18, 172-179.
13. Coughlin, S. R., Mawdsley, L., Mugarza, J. A., Wilding, J. P., and Calverley, P. M. (2007). Cardiovascular and metabolic effects of CPAP in obese men with OSA. Eur. Respir. J. 29, 720-727.
14. Cuhadaroglu, C., Utkusavas,A., Ozturk, L., Salman, S., and Ece, T. (2009). Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 187, 75-81.
15. Czupryniak, L., Loba, J., Pawlowski, M., Nowak, D., and Bialasiewicz, P. (2005). Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep 28, 601-603.
16. Dawson, A., Abel, S. L., Loving, R. T., Dailey, G., Shadan, F. F., Cronin, J. W., Kripke, D. F., and Kline, L. E. (2008). CPAP therapy of obstructive sleep apnea in type 2 diabet-icsimproves glycemic controlduring sleep. J. Clin. Sleep Med. 4, 538-542.
17. DeFronzo, R., Tobin, J., and Andres, R. (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Phys-iol. 237, E214-E223.
18. DeFronzo, R. A., and Abdul-Ghani, M. A. (2011). Preservation of beta-cell function: the key to diabetes prevention. J. Clin. Endocrinol. Metab. 96, 2354-2366.
19. Dorkova, Z., Petrasova, D., Mol-canyiova, A., Popovnakova, M., and Tkacova, R. (2008). Effects of CPAP on cardiovascular risk profile in patients withsevere obstructive sleep apnea and metabolic syndrome. Chest 134, 686-692.
20. Einhorn, D., Stewart, D. A., Erman, M. K., Gordon, N., Philis-Tsimikas, A., and Casal, E. (2007). Prevalence of sleep apnea in a population of adults withtype2 diabetes mellitus. Endocr. Pract. 13, 355-362.
21. Fendri,S., Rose, D., Myambu, S., Jeanne, S., and Lalau,J. D. (2011). Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome. Diabetes Res. Clin. Pract. 91, e21-e23.
22. Fletcher, E. C. (2003). Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26, 15-19.
23. Fletcher, E. C., Lesske, J., Culman, J., Miller, C. C., and Unger, T. (1992). Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20, 612-619.
24. Foster, G. D., Sanders, M. H., Mill-man, R., Zammit, G., Borradaile, K. E., Newman, A. B., Wadden, T. A., Kelley, D., Wing, R. R., Sun-yer, F. X., Darcey, V., and Kuna, S. T. (2009). Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32, 1017-1019.
25. Fredheim, J. M., Rollheim, J., Omland, T., Hofso, D., Roislien, J., Vegsgaard, K., and Hjelmesaeth, J. (2011). Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc. Diabetol. 10, 84.
26. Garcia, J. M., Sharafkhaneh, H., Hir-shkowitz, M., Elkhatib, R., and Sharafkhaneh, A. (2011). Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir. Res. 12, 80.
27. Gharib, S. A., Khalyfa, A., Abdelka-rim, A., Bhushan, B., and Gozal, D. (2012). Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PLoS ONE 7, e37669. doi:10.1371/journal.pone.0037669
28. Harsch, I. A., Schahin, S. P., Bruckner, K., Radespiel-Troger, M., Fuchs, F. S., Hahn, E. G., Konturek, P. C., Lohmann, T., and Ficker, J. H. (2004). The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71, 252-259.
29. Heffner, J. E., Rozenfeld, Y., Kai, M., Stephens, E. A., and Brown, L. K. (2012). Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 141, 1414-1421.
30. Henley, D. E., Russell, G. M., Douth-waite, J. A., Wood, S. A., Buchanan, F., Gibson, R., Woltersdorf, W. W., Catterall, J. R., and Lightman, S. L. (2009). Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J. Clin. Endocrinol. Metab. 94, 4234-4242.
31. Hoyos, C. M., Killick, R., Yee, B. J., Phillips, C. L., Grunstein, R. R., and Liu, P. Y. (2012). Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. doi: 10.1111/j.1365-2265.2012.04413.x. [Epub ahead of print].
32. Iiyori, N., Alonso, L. C., Li, J., Sanders, M. H., Garcia-Ocana,A.,O'Doherty, R. M., Polotsky,V.Y., and O'Donnell, C. P. (2007). Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med. 175, 851-857.
33. Ip, S., Lam, B., Ng, M., Lam, W., Tsang, K., and Lam, K. (2002). Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med. 165, 670-676.
34. Ip, S., Lam, K., Ho, C., Tsang, K., and Lam, W. (2000). Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118, 580-586.
35. Jun, J., and Polotsky, V. Y. (2009). Metabolic consequences of sleep-disordered breathing. ILAR J. 50, 289-306.
36. Kashyap, S. R., and Defronzo, R. A. (2007). The insulin resistance syndrome: physiological considerations. Diab. Vasc. Dis. Res. 4, 13-19.
37. Knowler, W. C., Barrett-Connor, E., Fowler,S. E., Hamman,R. F.,Lachin, J. M., Walker, E. A., and Nathan, D. M. (2002). Reduction in the inci-denceof type 2diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403.
38. Knowler, W. C., Fowler, S. E., Ham-man, R. F., Christophi, C. A., Hoff-man, H. J., Brenneman, A. T., Brown-Friday, J. O., Goldberg, R., Venditti, E., and Nathan, D. M. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374, 1677-1686.
39. Kohler, M., Stoewhas, A. C., Ayers, L., Senn, O., Bloch, K. E., Russi, E. W., and Stradling, J. R. (2011). Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 184, 1192-1199.
40. Kono, M., Tatsumi,K.,Saibara, T., Naka-mura, A., Tanabe, N., Takiguchi, Y., and Kuriyama, T. (2007). Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131, 1387-1392.
41. Laaban, J. P., Daenen, S., Leger, D., Pascal, S., Bayon, V., Slama, G., and Elgrably, F. (2009). Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab. 35, 372-377.
42. Lam, J. C., Lam, B., Yao, T. J., Lai, A. Y., Ooi, C. G., Tam, S., Lam, K. S., and Ip, M. S. (2010). A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur. Respir. J. 35, 138-145.
43. Levy, P., Bonsignore, M. R., and Eckel, J. (2009). Sleep, sleep-disordered breathing and metabolic consequences. Eur. Respir. J. 34, 243-260.
44. Lindberg, E., Berne, C., Elmasry, A., Hedner, J., and Janson, C. (2006). CPAP treatment of a population-based sample-what are the benefits and the treatment compliance? Sleep Med. 7, 553-560.
45. Lindberg, E., Theorell-Haglow, J., Svensson, M., Gislason, T., Berne, C., and Janson, C. (2012). Sleep apnea and glucose metabolism-a long-term follow-up in a community-based sample. Chest. doi: 10.1378/chest.11-1844. [Epub ahead of print].
46. Louis, M., and Punjabi, N. M. (2009). Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J. Appl. Physiol. 106, 1538-1544.
47. Mahmood, K., Akhter, N., Eldeirawi, K., Onal, E., Christman, J. W., Carley, D. W., and Herdegen,J. J. (2009). Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J. Clin. Sleep Med. 5, 215-221.
48. Marshall, N. S., Wong, K. K., Phillips, C. L., Liu, P. Y., Knuiman, M. W., and Grunstein, R. R. (2009). Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J. Clin. Sleep Med. 5, 15-20.
49. Matthews, D., Hosker, J., Rudenski, A., Naylor, B., Treacher, D., and Turner, R. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
50. Mazzone, T., Chait, A., and Plutzky, J. (2008). Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371, 1800-1809.
51. Meslier, N., Gagnadoux, F., Giraud, P., Person, C., Ouksel, H., Urban, T., and Racineux, J. L. (2003). Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur. Respir. J. 22, 156-160.
52. Mota, P. C., Drummond, M., Winck, J. C., Santos, A. C., Almeida, J., and Marques, J. A. (2011). APAP impact on metabolic syndrome in obstructive sleep apnea patients. Sleep Breath 15, 665-672.
53. Muraki, I., Tanigawa, T., Yamagishi, K., Sakurai, S., Ohira, T., Imano, H., Kitamura, A., Kiyama, M., Sato, S., Shimamoto, T., Konishi, M., and Iso, H. (2010). Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 53, 481-488.
54. Murri, M., Alcazar-Ramirez, J., Garrido-Sanchez, L., Linde, F., Alcaide, J., Cardona, F., and Tinahones, F. J. (2009). Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders insleep apnea-hypopnea syndrome patients. Transl. Res. 154, 111-121.
55. Nathan, D. M., Davidson, M. B., Defronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., and Zinman, B. (2007). Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753-759.
56. Newman, A. B., Foster, G., Givelber, R., Nieto, F. J., Redline, S., and Young, T. (2005). Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch. Intern. Med. 165, 2408-2413.
57. Nguyen, P. K., Katikireddy, C. K., McConnell, M. V., Kushida, C., and Yang, P. C. (2010). Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J. Cardiovasc. Magn. Reson. 12, 50.
58. Nieto, F. J., Peppard, P. E., and Young, T. B. (2009). Sleep disordered breathing and metabolic syndrome. WMJ 108, 263-265.
59. Oktay, B., Akbal, E., Firat, H., Ardic, S., and Kizilgun, M. (2009). CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up. Acta Clin. Belg. 64, 329-334.
60. Pallayova, M., Donic, V., and Tomori, Z. (2008). Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 81, e8-e11.
61. Pamidi, S.,Aronsohn,R.S., and Tasali,E. (2010). Obstructive sleep apnea: role in the risk and severity of diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 24, 703-715.
62. Pamidi, S., Wroblewski, K., Broussard, J., Day, A., Hanlon, E., Abraham, V., and Tasali, E. (2012). Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion. Diabetes Care (in press).
63. Peppard, P., Young, T., Palta, M., Dempsey, J., and Skatrud, J. (2000). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284, 3015-3021.
64. Pillai, A., Warren, G., Gunathilake, W., and Idris, I. (2011). Effects of sleep apneaseverity onglycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol. Ther. 13, 945-949.
65. Polotsky, V. Y., Li, J., Punjabi, N. M., Rubin, A. E., Smith, P. L., Schwartz, A. R., and O'Donnell, C. P. (2003). Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. (Lond.) 552, 253-264.
66. Polotsky, V. Y., Rubin, A. E., Balbir, A., Dean, T., Smith, P. L., Schwartz, A. R., and O'Donnell, C. P. (2006). Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse.Sleep Med.7,7-16.
67. Priou, P., Le Vaillant, M., Meslier, N., Chollet, S., Masson, P., Humeau, M. P., Pigeanne, T., Bizieux-Thaminy, A., Goupil, F., and Gagnadoux, F. (2012). Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care. PMID:22688546. [Epub ahead of print].
68. Punjabi, N. M. (2009). Do sleep disorders and associated treatments impact glucose metabolism? Drugs 69(Suppl. 2), 13-27.
69. Punjabi, N. M., and Beamer, B. A. (2009). Alterations in glucose disposal in sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 179, 235-240.
70. Punjabi, N. M., and Polotsky, V. Y. (2005). Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 99, 1998-2007.
71. Punjabi, N. M., Shahar, E., Redline, S., Gottlieb, D. J., Givelber, R., and Resnick, H. E. (2004). Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160, 521-530.
72. Punjabi,N. M., Sorkin,J. D., Katzel, L. I., Goldberg, A. P., Schwartz, A. R., and Smith, P. L. (2002). Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care Med. 165, 677-682.
73. Redline, S., Kapur, V. K., Sanders, M. H., Quan, S. F., Gottlieb, D. J., Rapoport, D. M., Bonekat, W. H., Smith, P. L., Kiley, J. P., and Iber, C. (2000). Effects of varying approaches for identify ing respiratory disturbances on sleep apnea assessment. Am. J. Respir. Crit. Care Med. 161, 369-374.
74. Redline, S., Yenokyan, G., Gottlieb, D. J., Shahar, E., O'Connor, G. T., Resnick, H. E., Diener-West, M., Sanders, M. H., Wolf,P. A., Geraghty, E. M., Ali, T., Lebowitz, M., and Punjabi, N. M. (2010). Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care Med. 182, 269-277.
75. Reichmuth, K. J., Austin, D., Skatrud, J. B., and Young, T. (2005). Association of sleep apnea and type II diabetes: a population-based study. Am. J. Respir. Crit. Care Med. 172, 1590-1595.
76. Resnick, H. E., Redline, S., Shahar, E., Gilpin, A., Newman, A., Walter, R., Ewy, G. A., Howard, B. V., and Punjabi, N. M. (2003). Diabetes and sleep disturbances:findingsfrom the Sleep Heart Health Study. Diabetes Care 26, 702-709.
77. Ronksley, P. E., Hemmelgarn, B. R., Heitman, S. J., Hanly, P. J., Faris, P. D., Quan, H., and Tsai, W. H. (2009). Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 64, 834-839.
78. Saarelainen, S., Lahtela, J., and Kallo-nen, E. (1997). Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J. Sleep Res. 6, 146-147.
79. Saini, J., Krieger, J., Brandenberger, G., Wittersheim, G., Simon, C., and Follenius, M. (1993). Continuous positive airway pressure treatment: effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm. Metab. Res. 25, 375-381.
80. Samson, P., Casey, K. R., Knepler, J., and Panos, R. J. (2012). Clinical characteristics, comorbidities, and response to treatment of veterans with obstructive sleep apnea, Cincinnati Veterans Affairs Medical Center, 2005-2007. Prev. Chronic. Dis. 9, E46.
81. Schahin, S. P., Nechanitzky, T., Dittel, C., Fuchs, F. S., Hahn, E. G., Kon-turek, P. C., Ficker, J. H., and Harsch, I. A. (2008). Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. Med. Sci. Monit. 14, CR117-CR121.
82. Seicean, S., Kirchner, H. L., Gottlieb, D. J., Punjabi, N. M., Resnick, H., Sanders, M., Budhiraja, R., Singer, M., and Redline, S. (2008). Sleep disordered breathing and impaired glucose metabolism in normal weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 31, 1001-1006.
83. Sharma, S. K., Agrawal, S., Damodaran, D., Sreenivas,V.,Kadhiravan, T.,Lak-shmy, R., Jagia, P., and Kumar, A. (2011). CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N. Engl. J. Med. 365, 2277-2286.
84. Shaw, J. E., Punjabi, N. M., Wilding, J. P., Alberti, K. G., and Zimmet, P. Z. (2008). Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res. Clin. Pract. 81, 2-12.
85. Shpirer, I., Rapoport, M. J., Stav, D., and Elizur, A. (2012). Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath 16, 461-466.
86. Sivam, S., Phillips, C. L., Trenell, M. I., Yee, B. J., Liu, P. Y., Wong, K. K., and Grunstein, R. R. (2012). Effects of 8 weeks of CPAP on abdominal adiposity in obstructive sleep apnoea. Eur. Respir. J. PMID: 22267762. [Epub ahead of print].
87. Smurra, M., Philip, P., Taillard, J., Guilleminault, C., Bioulac, B., and Gin, H. (2001). CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med. 2, 207-213.
88. Somers, V. K., White, D. P., Amin, R., Abraham, W. T., Costa, F., Cule-bras, A., Daniels, S., Floras, J. S., Hunt, C. E., Olson, L. J., Pickering, T. G., Russell, R., Woo, M., and Young, T. (2008). Sleep apnea and cardiovascular disease: an American HeartAssociation/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Coll. Cardiol. 52, 686-717.
89. Stamatakis, K. A., and Punjabi, N. M. (2009). Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 137, 95-101.
90. Steiropoulos, P., Kotsianidis, I., Nena, E., Tsara, V., Gounari, E., Hatz-izisi, O., Kyriazis, G., Christaki, P., Froudarakis, M., and Bouros, D. (2009). Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 32, 537-543.
91. Steiropoulos, P., Papanas, N., Nena, E., Tsara, V., Fitili, C., Tzouvelekis, A., Christaki, P., Maltezos, E., and Bouros, D. (2009). Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypop-nea Syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Med. 10, 887-891.
92. Stoohs, R., Facchini, F., and Guillem-inault, C. (1996). Insulin resistance and sleep-disordered breathing in healthy humans. Am. J. Respir. Crit. Care Med. 154, 170-174.
93. Tamisier, R., Gilmartin, G. S., Launois, S. H., Pepin, J. L., Nespoulet, H., Thomas, R., Levy, P., and Weiss, J. W. (2009). A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J. Appl. Physiol. 107, 17-24.
94. Tamura, A., Kawano, Y., Watanabe, T., and Kadota, J. (2008). Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir. Med. 102, 1412-1416.
95. Tasali, E., Chapotot, F., Leproult, R., Whitmore, H., and Ehrmann, D. A. (2011). Treatment of obstructive sleep apnea improves cardiometa-bolic function in young obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 96, 365-374.
96. Tasali, E., and Ip, M. S. (2008). Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation.Proc. Am. Thorac. Soc. 5, 207-217.
97. Tasali, E., Leproult, R., Ehrmann, D. A., and Van Cauter, E. (2008). Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. U.S.A. 105, 1044-1049.
98. Tasali, E., Mokhlesi, B., and Van Cauter, E. (2008). Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133, 496-506.
99. Theorell-Haglow, J., Berne, C., Janson, C., Svensson, M., and Lindberg, E. (2006). Is obstruction sleep apnea associated with the metabolic syndrome and impaired glucose metabolism. Sleep Med. 7(Suppl. 2), S5.
100. Trenell, M. I., Ward, J. A., Yee, B. J., Phillips, C. L., Kemp, G. J., Grun-stein, R. R., and Thompson, C. H. (2007). Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes. Metab. 9, 679-687.
101. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salmi-nen, V., and Uusitupa, M. (2001). Prevention of type 2 diabetes mel-litus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350.
102. Vgontzas, A. N., Zoumakis, E., Bixler, E. O., Lin, H. M., Collins, B., Basta, M., Pejovic, S., and Chrousos, G. P. (2008). Selective effects of CPAP on sleep apnoea-associated manifestations. Eur. J. Clin. Invest. 38, 585-595.
103. Weinstock, T. G., Wang, X., Rueschman, M., Ismail-Beigi, F., Aylor, J., Babineau, D. C., Mehra, R., and Redline, S. (2012). A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 35, 617B-625B.
104. West, S. D., Nicoll, D. J., Wallace, T. M., Matthews, D. R., and Stradling, J. R. (2007). Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62, 969-974.
105. Xu, J., Long,Y. S., Gozal, D., and Epstein, P. N. (2009). Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic. Biol. Med. 46, 783-790.
106. Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., and Mohsenin, V. (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353, 2034-2041.
107. Yokoe, T., Alonso, L. C., Romano, L. C., Rosa, T. C., O'Doherty, R. M., Garcia-Ocana, A., Minoguchi, K., and O'Donnell, C. P. (2008). Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J. Physiol. (Lond.) 586, 899-911.
108. Young, T., Finn, L., Peppard, P. E., Szklo-Coxe, M., Austin, D., Nieto, F. J., Stubbs, R., and Hla, K. M. (2008). Sleep disordered breathing andmor-tality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31, 1071-1078.
109. Young, T., Peppard, P. E., and Taheri, S. (2005). Excess weight and sleep-disordered breathing. J. Appl. Phys-iol. 99, 1592-1599.